Lauren is an associate in the firm’s litigation and enforcement practice group, where her practice focuses on internal and government investigations and complex securities litigation.
Lauren is a contributor to Ropes & Gray’s AI Court Order Tracker and provides litigation updates on matters relating to artificial intelligence. Lauren maintains an active pro bono practice and is working to defend the legality of Deferred Action for Childhood Arrivals in the United States District Court for the Southern District of Texas and the rights of Jewish students and their families in the United States District Court for the Northern District of California.
At Brooklyn Law School, Lauren served as the executive notes & comments editor for the Journal of Law and Policy. During law school, Lauren interned in the Civil Division of the United States Attorney’s Office for the Southern District of New York, the Enforcement Division of the Securities and Exchange Commission, and for Judge Ramon E. Reyes, Jr. in the Eastern District of New York.
Experience
Government Enforcement
- Obtained close of civil regulatory investigation for biotechnology company
- Represent venture capital firm in parallel civil regulatory and criminal investigations regarding alleged misstatements by portfolio company
- Represent healthcare client in parallel federal and state regulatory investigations involving alleged violations of False Claims Act and Stark Law
- Represent biotechnology and immunotherapy companies in civil regulatory investigations
- Represent publicly-traded company and its directors in civil regulatory investigations
Securities Litigation
- Obtained favorable settlement for former directors of sponsor in putative securities class action arising from de-SPAC transaction
- Obtained favorable settlement for outside directors of publicly-traded company in parallel securities and derivative class actions
- Obtained favorable settlement for public company in putative securities class action arising from statements made during IPO
- Represent biotechnology and immunotherapy companies in securities class actions and related shareholder derivative actions